Viewing nowAtorogen Tablets 10 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

MFDS item code 201602875 · Approved 2016.05.23 · Insurance code 073001440
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases. Particularly, it lowers the risk of myocardial infarction and stroke in adult patients who have risk factors for coronary heart disease or type 2 diabetes. Furthermore, in adult patients who already have coronary heart disease, it lowers the risks of non-fatal myocardial infarction, stroke, the need for revascularization, congestive heart failure hospitalization, and angina. This medication is also used to treat hyperlipidemia, effectively lowering total cholesterol, LDL cholesterol, and triglyceride levels, while increasing HDL cholesterol. It is especially used as an adjunct therapy for patients with dyslipidemia who do not respond to dietary therapy. It helps reduce cholesterol levels in pediatric patients aged 10 to 17 with heterozygous familial hypercholesterolemia. Overall, it is used to improve cardiovascular health and treat hyperlipidemia.
Patients receiving atorvastatin, or about to start treatment with it, should follow a standard cholesterol-lowering diet. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (40 mg only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. As the goal of treatment is to lower LDL cholesterol, measurement of LDL cholesterol is recommended when initiating treatment and evaluating response. However, if LDL cholesterol levels cannot be measured, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Elderly patients: Efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.
Age 10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this medicine higher than 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for the individual patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may present symptoms affecting the muscles. If there is severe muscle pain or weakness, or if creatine kinase levels become significantly elevated, discontinue use immediately and consult a physician. This medication should not be used in patients with certain diseases or conditions, such as those with severely impaired liver function, muscle disorders, women who are pregnant or breastfeeding, children under 10 years old, or patients taking certain medications. Patients with liver or kidney problems or alcohol dependence need to exercise caution when using this medication and should have regular liver function tests before and during treatment. This medication can cause rare but serious side effects, such as interstitial lung disease or severe myasthenia gravis, so report breathing difficulties or muscle weakness symptoms to medical personnel immediately. This medication can interact with several other drugs; thus, it is essential to inform your physician or pharmacist about any other medications you are taking, especially when combined with specific antibiotics, antifungals, antivirals, blood pressure medications, antidiabetics, and oral contraceptives. Women who are pregnant or may become pregnant must use appropriate contraceptive methods while taking this medication and discontinue it immediately if pregnancy is confirmed. If symptoms such as muscle pain, fatigue, or fever occur during treatment, report them to your physician promptly for evaluation, especially if muscle-related symptoms are severe, as treatment may need to be discontinued. Children and elderly patients require special attention when using this medication, particularly because elderly patients face a higher risk of myopathy, making monitoring critical. In cases of overdose, there is no specific antidote, and treatment should focus on symptom management while monitoring liver function and muscle enzyme levels. This medication should be stored out of the reach of children and kept in its original container to prevent misuse or quality deterioration.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius to preserve the medication's effectiveness and safety.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.